Vimarsana
Biggest News Aggregation in the World

Peter Foertig News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Foertig. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Foertig Today - Breaking & Trending Today

European Commission Grants Conditional Marketing Authorization for Taiho's LYTGOBI® Tablets for the Treatment of Adults With Cholangiocarcinoma - Vimarsana News

European Commission Grants Conditional Marketing Authorization for Taiho's LYTGOBI® Tablets for the Treatment of Adults With Cholangiocarcinoma

Published: July 4, 2023

/PRNewswire/ -- Taiho Oncology Europe GmbH and Taiho Pharmaceutical Co., Ltd., announced today that the European Commission has granted conditional marketing...

Source: prnewswire.com
Related Topics:
United KingdomGastroenterol HepatolEurope Gmbh ZugPeter FoertigJudy Kay MooreAtsushi AzumaEurope GmbJunko OnishiHelen MorementEuropean UnionTaiho Pharmaceutical Co LtdUniversity College London HospitalsCholangiocarcinoma CharityOncologist At University College London Cancer InstituteOtsuka Holdings Co LtdEuropean CommissionOncology Europe GmbhVice PresidentMedical AffairsTaiho OncologyJohn BridgewaterSenior AuthorNew England JournalClinical ResearcherMedical Oncologist
CHMP ISSUES POSITIVE OPINION FOR FUTIBATINIB FOR THE TREATMENT OF ADULTS WITH CHOLANGIOCARCINOMA - Vimarsana News

CHMP ISSUES POSITIVE OPINION FOR FUTIBATINIB FOR THE TREATMENT OF ADULTS WITH CHOLANGIOCARCINOMA

Published: April 27, 2023

/PRNewswire/ -- Taiho Oncology Europe GmbH and Taiho Pharmaceutical Co., Ltd. announced today that the European Medicines Agency's (EMA) Committee for...

Source: prnewswire.com
Related Topics:
Intrahepatic CholangiocarcinomaArndt VogelJunko OnishiEurope Gmbh ZugPeter FoertigTakeshi SagaraJudy Kay MooreEurope GmbGuidelines CommitteeEuropean UnionHannover Medical SchoolEuropean Medicines AgencyDepartment Of GastroenterologyOtsuka Holdings Co LtdClinical DevelopmentEuropean CommissionTaiho Pharmaceutical Co LtdCommittee For Medicinal Products Human UsePreclinical Research At TaihoOncology Europe GmbhMedicinal ProductsHuman UseVice PresidentMedical AffairsTaiho Oncology
Taiho Oncology Europe GmbH: CHMP ISSUES POSITIVE OPINION FOR FUTIBATINIB FOR THE TREATMENT OF ADULTS WITH CHOLANGIOCARCINOMA - Vimarsana News

Taiho Oncology Europe GmbH: CHMP ISSUES POSITIVE OPINION FOR FUTIBATINIB FOR THE TREATMENT OF ADULTS WITH CHOLANGIOCARCINOMA

Published: April 27, 2023

ZUG, Switzerland, April 27, 2023 /PRNewswire/ -- Taiho Oncology Europe GmbH and Taiho Pharmaceutical Co., Ltd. announced today that the European Medicines Agency's (EMA) Committee for Medicinal

Source: finanznachrichten.de
Related Topics:
Takeshi SagaraArndt VogelIntrahepatic CholangiocarcinomaEurope Gmbh ZugEurope GmbJudy Kay MooreJunko OnishiPeter FoertigGuidelines CommitteeHannover Medical SchoolEuropean UnionCommittee For Medicinal Products Human UseOtsuka Holdings Co LtdClinical DevelopmentEuropean Medicines AgencyPreclinical Research At TaihoDepartment Of GastroenterologyTaiho Pharmaceutical Co LtdEuropean CommissionOncology Europe GmbhMedicinal ProductsHuman UseVice PresidentMedical AffairsTaiho Oncology